A 71-Year-Old Woman With Relapsed/Refractory Follicular Lymphoma

Hematology/oncology expert, John P. Leonard, MD, describes the rationale for treating an elderly patient with relapsed/refractory follicular lymphoma with a PI3K inhibitor in the third-line setting.